Trials / Conditions / Cushing's Syndrome

Cushing's Syndrome

32 registered clinical trials studyying Cushing's Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hype NCT06246357	National Cancer Institute (NCI)	Phase 2
Enrolling By Invitation	Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors NCT07182175	Peking University First Hospital	—
Recruiting	Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome NCT07350707	Peking Union Medical College Hospital	Phase 1 / Phase 2
Completed	Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome NCT05633953	RECORDATI GROUP	—
Completed	Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 NCT03606408	RECORDATI GROUP	Phase 2
Completed	Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease NCT03817840	Columbia University	—
Completed	Contralateral Adrenal Volume Predicts Duration of Postoperative Steroid Replacement Therapy in Non-ACTH-depend NCT07282223	Peking University First Hospital	—
Completed	Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery NCT02922257	Corcept Therapeutics	—
Completed	Study to Evaluate CORT125134 in Participants With Cushing's Syndrome NCT02804750	Corcept Therapeutics	Phase 2
Completed	Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome NCT02663609	Corcept Therapeutics	—
Completed	Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome NCT02468193	Novartis Pharmaceuticals	Phase 2
Completed	Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome NCT02297945	HRA Pharma	Phase 3
Recruiting	Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome NCT02019706	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 2
Completed	In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man NCT02889224	University Hospital, Bordeaux	N/A
Unknown	Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's NCT01504555	Haukeland University Hospital	—
Completed	Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syn NCT01371565	Corcept Therapeutics	Phase 3
Completed	An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome NCT00936741	Corcept Therapeutics	Phase 3
Terminated	A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercorti NCT00796783	Corcept Therapeutics	—
Terminated	Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome NCT00682084	University of Aarhus	—
Completed	A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome NCT00569582	Corcept Therapeutics	Phase 3
Terminated	Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing NCT00422201	HRA Pharma	Phase 2
Completed	Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenale NCT01959711	Jagiellonian University	Phase 4
Active Not Recruiting	Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma NCT00457587	University of Wuerzburg	—
Completed	A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease NCT00088608	Novartis Pharmaceuticals	Phase 2
Completed	Diagnostic Performance of Screening Tests for Cushing s Syndrome NCT00361777	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	Study of Cushing's Syndrome Not Related to ACTH Production NCT00006278	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Unknown	Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome NCT00004343	National Center for Research Resources (NCRR)	—
Completed	Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and NCT00001452	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome NCT00001453	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome NCT00004326	National Center for Research Resources (NCRR)	—
Unknown	Study of Depression, Peptides, and Steroids in Cushing's Syndrome NCT00004334	National Center for Research Resources (NCRR)	—
Completed	Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and NCT00001180	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—